Washington, NJ, United States of America

Danny Roland Howard, Jr

This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignees: Novartis Ag, Palobiofarma S.l.. Active years: 2020-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Danny Roland Howard, Jr. Retrieved from https://idiyas.com/inventor/danny-roland-howard-jr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 33.3

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2020-2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Danny Roland Howard, Jr: A Pioneer in Cancer Treatment Innovations

Introduction

Danny Roland Howard, Jr. is an accomplished inventor based in Washington, NJ, whose remarkable contributions to the field of cancer treatment are underscored by his two patents. His work focuses on innovative compounds that target cancer at a molecular level, providing new avenues for therapeutic intervention.

Latest Patents

Danny's most recent patents include significant breakthroughs in the use of specific compounds for cancer therapy. The first patent, 1-(4-amino-5-bromo-6-(1H-pyrazol-1-yl)pyrimidin-2-yl)-1H-pyrazol-4-ol, relates to an active metabolite known to modulate the activity of the adenosine A2a receptor. This invention emphasizes pharmaceutical compositions that incorporate this compound, as well as its preparation processes for use in cancer treatments, either alone or in combination with immunotherapeutic agents. The second patent discusses 5-bromo-2,6-di-(1H-pyrazol-1-yl)pyrimidin-4-amine and its pharmaceutical compositions for treating cancer, including its acceptable salts and co-crystals. These innovations represent significant strides in the fight against cancer.

Career Highlights

Throughout his career, Danny has made impactful contributions while working with notable companies such as Novartis AG and Palobiofarma S.L. His experience in these leading firms has allowed him to develop and refine his innovative ideas, positioning him as a thought leader in pharmaceutical research and development.

Collaborations

Danny has had the opportunity to collaborate with talented individuals like Sanela Bilic and Juan Alberto Camacho Gomez. These partnerships have likely enriched his research and contributed to the successful results of his innovations, fostering an environment of creativity and scientific progress.

Conclusion

Danny Roland Howard, Jr. stands out as an influential inventor in the realm of cancer treatment. Through his patents and collaborative efforts, he continues to contribute valuable solutions that have the potential to transform cancer therapies and improve patient outcomes. His work is a testament to the impact that dedicated inventors can have on global health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…